“My belief in Leronlimab is buoyed by watching the talent of the management and board continually get strengthened by attracting new impressive people. If they saw a ship with holes in it, they would bail in mass. We have calmed ourselves into hoping Monday AM is positive and I think it may just be.”

I agree. That Monday may just be positive. Let’s get out of the way that of course I have no idea.

But…in 2022 it’s a new development that we get a PR that is not part of a quarterly update. Out of the blue so to speak. While the axing of the BLA is major news, it does break the cadence the Antonio announced in Q1.

My only other thought about Monday SP, is that shedding expenses and clarifying purpose, as painful as it may be for us long haulers, sometimes increases profit potential to savvy investors.

Suppose I’m being hopeful, and as usual we’ll find out together.

Concerning “bailing in mass,” this is the main reason Scott Kelly stayed on. His absence in January would have burnt the boat.

Read More: https://investorshangout.com/post/view?id=649...z7jA92hlk5